Navigation Links
Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research

have not received prior chemotherapy for advanced disease.

Head and Neck Cancer

Taxotere(R) in combination with cisplatin and fluorouracil is indicated for the induction treatment of patients with inoperable locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Important safety information

WARNING: Taxotere(R) treatment can cause serious, physically limiting, and potentially life-threatening side effects, such as infection, low blood-cell counts, allergic reaction and retention of excess fluid (edema).

Taxotere(R) in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic NSCLC who have not previously received chemotherapy for this condition.

Taxotere(R) should not be given to patients with low white-blood-cell counts, abnormal liver function, or a history of allergic reactions to Taxotere(R) or any of the ingredients in Taxotere(R).

Before each Taxotere(R) treatment, all patients treated with Taxotere(R) must receive another medicine called dexamethasone. This drug can help reduce the risk of fluid retention (edema) and allergic reactions.

Taxotere(R) should be administered only under the supervision of a qualified physician experienced in the use of anticancer treatments. Appropriate management of complications is possible only when adequate diagnostic and treatment facilities are readily available.

Treatment-related acute myeloid leukemia (AML) has occurred in patients given anthracyclines and/or cyclophosphamide, including use with Taxotere(R) in adjuvant therapy for breast cancer. The most common severe side effects are low white-blood-cell count, anemia, fatigue, diarrhea, and mouth and throat irritation. Low white-blood-cell count can lead to life-threatening infections. The earliest sign of infection may be fever, so tell your doctor right away if you have a fever. Other common side effects from Taxotere(R) include
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
4. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
7. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
8. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
9. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
10. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
11. New Data Presented on Micardis (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes
Post Your Comments:
(Date:8/26/2014)... 2014  Kewaunee Scientific Corporation (Nasdaq: KEQU ... July 31, 2014. Sales for the quarter ... the first quarter last year. Net earnings for the ... compared to net earnings of $1,587,000, or $0.61 per ... year. However, both sales and earnings in the first ...
(Date:8/26/2014)... YORK , Aug. 26, 2014 /PRNewswire/ ... research report is available in its catalogue: ... Outlook to 2020 ... Gastroscopes Market Outlook to 2020 Summary ... Gastroscopes Market Outlook to 2020", provides key ...
(Date:8/26/2014)... Del. , Aug. 26, 2014 Biomedical ... it has been named to the prestigious 2014 Inc. ... are honored to be included on this prestigious list ... said Chris Jacob , Biomedical Research Laboratories, CEO. ... and further serves to validate the hard work and ...
Breaking Medicine Technology:Kewaunee Scientific Reports Results for First Quarter 2Kewaunee Scientific Reports Results for First Quarter 3Kewaunee Scientific Reports Results for First Quarter 4Kewaunee Scientific Reports Results for First Quarter 5Kewaunee Scientific Reports Results for First Quarter 6Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 2Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 3Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 4Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 5Biomedical Research Laboratories Named to Inc. 500 List of America's Fastest-Growing Companies 2
(Date:8/27/2014)... chemicals, which repel water and oil and are ... industrial processing. These characteristics have made the fluorochemicals ... coatings for food paper and board. , The ... to break down and accumulate in both humans ... with harmful health effects, such as cancer, increased ...
(Date:8/27/2014)... When a friend invited Misty Mozejko to join ... was the beginning of a new way of life and a ... Misty. “I knew I needed to turn my life around but ... been, Misty stuck with the program. “It was so difficult,” she ... of my comfort zone, but between the boot camp and some ...
(Date:8/27/2014)... 27, 2014 According to market research ... Servo), Power Range (Micro, Low, Medium, High), Voltage (Low ... and Geography - Global Market Trends & Forecast to ... market with an analysis and forecast of the market ... an estimated $16.64 billion in 2014 to $22.73 billion ...
(Date:8/27/2014)... 27, 2014 Humility of Mary Health ... St. Elizabeth Boardman Health Center in Boardman beginning Sept. ... Niles beginning Sept. 8. , SlimDown teaches participants to ... to food, physical activity and behavior. , Classes run ... Boardman Health Center and Mondays at St. Joe’s at ...
(Date:8/27/2014)... Ellen V. Krieger, DDS released a new video describing her ... to describe the business and industry best practices for ... of cosmetic and family dentistry experience, Dr Ellen Krieger is ... and cared for. , Dr. Krieger has practiced dentistry in ... solid reputation of offering bright, friendly service to all of ...
Breaking Medicine News(10 mins):Health News:Leading scientists call for a stop to non-essential use of fluorochemicals 2Health News:Leading scientists call for a stop to non-essential use of fluorochemicals 3Health News:Whitby Fit Body Boot Camp Releases Gift Certificate for Two-Week Complimentary Access to Fitness Boot Camp 2Health News:Whitby Fit Body Boot Camp Releases Gift Certificate for Two-Week Complimentary Access to Fitness Boot Camp 3Health News:Variable Frequency Drives Market Worth $22.73 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Humility of Mary Health Partners Offers SlimDown Classes 2Health News:Ellen V. Krieger, DDS of McLean, Virginia Announces New Video Describing Industry Best Practices 2
... MYL ),today announced that in accordance with its 2.139 ... dividend of $16.25 per,share (based on the annual dividend ... share) payable on May 15, 2008, to holders of,preferred ... Mylan Inc., with operations in more than 90 countries, ...
... "Cover the Uninsured Week," an,annual campaign that ... million,Americans who live without health insurance., ... PFE ) at:, http://media.medialink.com/WebNR.aspx?story=35042 , ... graphics and,photos for free and unrestricted use ...
... /PRNewswire-FirstCall/ - SXC Health Solutions,Corp. ("SXC" or the "Company") ... indirect, wholly-owned subsidiary has accepted for payment and,exchange all ... all,outstanding shares of common stock of National Medical Health ... share price of $7.70 in cash, without,interest, and 0.217 ...
... Say McCain Health Plan Dismantles Employer-based Health Care, ... Negative Impact, WASHINGTON, April 29 Sen. ... system that covers,more than 60 percent of non-elderly ... experts responding to the announcement of his proposal,today. ...
... dropout rate, study says , , TUESDAY, April 29 (HealthDay ... those not currently injecting drugs, are most likely to ... , University of Kent and Kings College London researchers ... programs and found that 25 percent left the programs ...
... treatments, two studies suggest , , TUESDAY, April 29 (HealthDay ... of gene variants linked to bone density and the risk ... While not a predictor of individual risk for osteoporosis, this ... they noted. , "When we look at a screening of ...
Cached Medicine News:Health News:SXC Health Solutions announces completion of exchange offer for NMHC 2Health News:SXC Health Solutions announces completion of exchange offer for NMHC 3Health News:SXC Health Solutions announces completion of exchange offer for NMHC 4Health News:McCain Would Drive Up Health Care Costs for Families, While Benefiting Health Insurance Companies 2Health News:McCain Would Drive Up Health Care Costs for Families, While Benefiting Health Insurance Companies 3Health News:Youngest Drug Users Most Likely to Leave Treatment Programs 2Health News:Genes Linked to Osteoporosis Identified 2Health News:Genes Linked to Osteoporosis Identified 3
... Single PCMCIA card provides diagnostic ... Burdicks SpiroCard is on a PCMCIA ... portable package. SpiroCard card,is full-featured and ... conventional,instrument. The device interfaces to Office,Medic ...
ASAP™ Automated Biopsy System with Channel Cut™ Needle....
Incontinence Pessaries...
The Set comes with a cross reference chart that translates ring size into the correct size of other EvaCare pessaries. The Fitting Set can be disinfected in three ways: autoclaved, boiled or cold ste...
Medicine Products: